Chronic and cycling hypoxia: drivers of cancer chronic inflammation through HIF-1 and NF-κB activation: a review of the molecular mechanisms

J Korbecki, D Simińska… - International journal of …, 2021 - mdpi.com
Chronic (continuous, non-interrupted) hypoxia and cycling (intermittent, transient) hypoxia
are two types of hypoxia occurring in malignant tumors. They are both associated with the …

What are reactive oxygen species, free radicals, and oxidative stress in skin diseases?

K Nakai, D Tsuruta - International journal of molecular sciences, 2021 - mdpi.com
Oxygen in the atmosphere is a crucial component for life-sustaining aerobic respiration in
humans. Approximately 95% of oxygen is consumed as energy and ultimately becomes …

Current advances of nitric oxide in cancer and anticancer therapeutics

J Mintz, A Vedenko, O Rosete, K Shah, G Goldstein… - Vaccines, 2021 - mdpi.com
Nitric oxide (NO) is a short-lived, ubiquitous signaling molecule that affects numerous critical
functions in the body. There are markedly conflicting findings in the literature regarding the …

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

T Lu, R Ramakrishnan, S Altiok, JI Youn… - The Journal of …, 2011 - Am Soc Clin Investig
Cancer immunotherapeutic approaches induce tumor-specific immune responses, in
particular CTL responses, in many patients treated. However, such approaches are clinically …

Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer

B Delage, DA Fennell, L Nicholson… - … journal of cancer, 2010 - Wiley Online Library
Arginine, a semi‐essential amino acid in humans, is critical for the growth of human cancers,
particularly those marked by de novo chemoresistance and a poor clinical outcome. In …

Inflammation and cancer: how friendly is the relationship for cancer patients?

BB Aggarwal, P Gehlot - Current opinion in pharmacology, 2009 - Elsevier
Evidence has emerged in the last two decades that at the molecular level most chronic
diseases, including cancer, are caused by a dysregulated inflammatory response. The …

Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook

R Wu, MA Forget, J Chacon, C Bernatchez… - The Cancer …, 2012 - journals.lww.com
Immunotherapy using autologous T cells has emerged to be a powerful treatment option for
patients with metastatic melanoma. These include the adoptive transfer of autologous tumor …

Immune resistance orchestrated by the tumor microenvironment

TF Gajewski, Y Meng, C Blank, I Brown… - Immunological …, 2006 - Wiley Online Library
It is now little disputed that most if not all cancer cells express antigens that can be
recognized by specific CD8+ T lymphocytes. However, a central question in the field of anti …

Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapy

EN Tcyganov, E Sanseviero, D Marvel, T Beer… - Cancer cell, 2022 - cell.com
Cancer immunotherapy often depends on recognition of peptide epitopes by cytotoxic T
lymphocytes (CTLs). The tumor microenvironment (TME) is enriched for peroxynitrite (PNT) …

Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma

P Bailey, DK Chang, MA Forget, FAS Lucas… - Scientific reports, 2016 - nature.com
Immunotherapy approaches for pancreatic ductal adenocarcinoma (PDAC) have met with
limited success. It has been postulated that a low mutation load may lead to a paucity of T …